Veterinary Internal Medicine High-Yield Topics for the NAVLE

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Hyperadrenocorticism diagnosis follows a screening (e.g., low-dose dexamethasone suppression test, urine cortisol:creatinine ratio) then differentiation (e.g., endogenous ACTH, high-dose dexamethasone suppression) strategy to identify cortisol excess and its source. Hypoadrenocorticism is suggested by hyperkalemia, hyponatremia, and azotemia, with ACTH stimulation testing as the gold standard for confirmation, distinguishing primary from atypical forms based on mineralocorticoid deficiency.
• Chronic kidney disease (CKD) staging utilizes IRIS guidelines based on creatinine and SDMA, further substaged by proteinuria (UPC) and blood pressure, guiding management with dietary protein/phosphorus restriction, blood pressure control, and treatment of secondary complications like anemia. Acute kidney injury (AKI) differentiation hinges on distinguishing prerenal, renal, and postrenal azotemia via urinalysis, urine sediment, and fluid response, with specific nephrotoxins (lilies in cats, grapes in dogs) being high-yield topics.
• Inflammatory bowel disease (IBD) is an exclusionary diagnosis requiring histopathology after ruling out food-responsive and antibiotic-responsive enteropathies; dietary trials precede immunosuppressive therapy. Pancreatitis diagnosis in dogs relies on vomiting, abdominal pain, and cPLI, while feline pancreatitis is often indolent with nonspecific signs and requires fPLI and advanced imaging, frequently coexisting with cholangitis and IBD.
• Dyspnea requires differentiating cardiac from pulmonary causes using thoracic imaging and point-of-care ultrasound, not immediate diuretic administration. Feline asthma and chronic bronchitis are distinguished by radiographic findings, BAL cytology, and response to bronchodilators versus corticosteroids, with beta-agonist monotherapy contraindicated in asthma.
• Vector-borne diseases like ehrlichiosis and anaplasmosis are tested across species, emphasizing geographic distribution and diagnostic limitations of serology versus PCR. Reportable diseases necessitate knowledge of reporting pathways and regulatory frameworks, with WOAH standards defining international notification requirements.
• Anemia is classified by regenerative status (reticulocyte response) and RBC morphology, guiding further diagnostics for immune-mediated hemolytic anemia (spherocytes) or microangiopathic disease (acanthocytes). Thrombocytopenia and coagulopathy differentiate primary (platelet count, vWF) from secondary (vitamin K antagonist toxicity, DIC) hemostatic disorders using buccal mucosal bleeding time and coagulation panels.
• Endocrine emergencies like diabetic ketoacidosis (DKA) are diagnosed by hyperglycemia, ketonemia/ketonuria, and metabolic acidosis, managed with isotonic crystalloids, regular insulin CRI, and potassium supplementation, monitoring glucose closely. Hypoadrenocorticism stabilization involves 0.9% saline, glucocorticoids, and mineralocorticoids, with ACTH stimulation testing crucial for diagnosis, while atypical forms lack electrolyte abnormalities.

This article curates the internal medicine topics most frequently tested on the North American Veterinary Licensing Examination (NAVLE), with emphasis on common diseases, diagnostic reasoning, and management frameworks across companion animal, equine, and food animal species. It serves veterinary students preparing for board examination and clinicians seeking a structured review of core internal medicine content. The material addresses the clinical questions most likely to appear in examination items: distinguishing similar presentations, selecting first-line diagnostics, and identifying monitoring parameters that determine therapeutic success.

The NAVLE assesses clinical reasoning across the full spectrum of veterinary practice, and internal medicine constitutes a substantial portion of the examination blueprint. The International Council for Veterinary Assessment publishes the official examination structure and content domains, which candidates should consult when allocating study time. This review prioritizes conditions with high clinical frequency and examination recurrence, organized by body system and pathophysiologic mechanism.

At a Glance

Pathophysiologic Foundations of Common Endocrine Disorders

Endocrine disease appears consistently on the NAVLE because it requires integration of physiology, diagnostic testing, and long-term management. The hypothalamic-pituitary axis governs most tested endocrinopathies, and examination items frequently probe the feedback relationships that explain laboratory abnormalities.

Hyperadrenocorticism results from excessive cortisol production, either pituitary-dependent or adrenal-dependent. The diagnostic logic flows from screening to differentiation: screening tests detect cortisol excess, while differentiation tests identify the source. The low-dose dexamethasone suppression test and urine cortisol-to-creatinine ratio serve as screening tools, with the ACTH stimulation test reserved for specific contexts such as suspected iatrogenic disease. Differentiation relies on endogenous ACTH concentration or high-dose dexamethasone suppression. Examination items commonly test the interpretation of discordant results, such as a dog with normal ACTH stimulation but abnormal low-dose suppression.

Hypoadrenocorticism presents the inverse problem. The classic clinicopathologic triad of hyperkalemia, hyponatremia, and azotemia in a young to middle-aged dog strongly suggests the diagnosis, but the sodium-to-potassium ratio alone does not confirm it. The ACTH stimulation test remains the gold standard, and examination items frequently test the distinction between primary and atypical disease, where electrolyte abnormalities are absent. The pathophysiology of mineralocorticoid versus glucocorticoid deficiency explains this distinction and should be understood before memorizing test protocols.

Renal Disease: Staging and Management Logic

Chronic kidney disease (CKD) is among the most common internal medicine presentations in small animal practice and a frequent examination topic. The International Renal Interest Society (IRIS) staging system, described in the MSD Veterinary Manual professional edition, provides the framework for both examination answers and clinical decisions. Staging is based on fasting creatinine and symmetric dimethylarginine (SDMA), with substaging by proteinuria and systolic blood pressure. Examination items test the ability to assign a stage from laboratory values and then select appropriate management based on that stage.

The pathophysiology of CKD progression involves hyperfiltration, glomerular hypertension, and tubulointerstitial fibrosis. Management targets these mechanisms through dietary protein and phosphorus restriction, blood pressure control, and management of secondary complications including anemia and metabolic acidosis. The examination frequently tests the rationale behind these interventions, also their names.

Acute kidney injury (AKI) requires a different diagnostic framework. The distinction between prerenal, renal, and postrenal azotemia is a foundational examination concept. Urine specific gravity, urine sediment, and response to fluid therapy differentiate these categories. Nephrotoxin exposure, particularly from lilies in cats and grapes in dogs, represents a high-yield subset of AKI items.

Gastrointestinal Disease: Diagnostic Hierarchies

Chronic enteropathy in dogs and cats encompasses a spectrum from food-responsive to antibiotic-responsive to steroid-responsive disease. The examination tests the diagnostic hierarchy: dietary trials precede immunosuppressive therapy, and histopathology confirms inflammatory bowel disease only after other causes are excluded. The MSD Veterinary Manual professional edition provides the standard approach to this diagnostic ladder.

Pancreatitis in dogs and cats presents with species-specific differences that examination items exploit. Canine pancreatitis typically presents with vomiting, cranial abdominal pain, and elevated pancreatic lipase immunoreactivity. Feline pancreatitis is more often indolent, with nonspecific signs such as anorexia and lethargy, and frequently coexists with inflammatory bowel disease and cholangitis, the so-called triaditis. The diagnostic approach differs accordingly, with feline cases requiring more aggressive imaging and biopsy.

Exocrine pancreatic insufficiency presents with weight loss, polyphagia, and voluminous feces. Serum trypsin-like immunoreactivity confirms the diagnosis in dogs, while feline cases require a different assay. The response to enzyme replacement therapy is rapid and dramatic, and examination items frequently test this therapeutic trial as both diagnostic confirmation and management.

Respiratory and Cardiovascular Integration

The respiratory and cardiovascular systems are tested together because dyspnea requires distinguishing cardiac from pulmonary causes. The diagnostic approach begins with thoracic imaging and point-of-care ultrasound, not with diuretic administration. Examination items test the ability to differentiate congestive heart failure from primary respiratory disease based on radiographic patterns, echocardiographic findings, and response to therapy.

Feline asthma and chronic bronchitis represent a common differential pair. The distinction rests on radiographic findings, bronchoalveolar lavage cytology, and response to bronchodilators versus corticosteroids. Examination items frequently test the contraindication of beta-agonist monotherapy and the central role of glucocorticoids in feline asthma management.

Infectious Disease Frameworks

Infectious disease items on the NAVLE require understanding of transmission, diagnostic testing, and zoonotic potential. Vector-borne diseases such as ehrlichiosis, anaplasmosis, and Lyme disease are tested across species, with emphasis on the geographic distribution and the diagnostic limitations of serology versus polymerase chain reaction.

Reportable diseases require knowledge of the reporting pathway and the regulatory framework. The WOAH terrestrial animal health standards define international notification requirements, while domestic reporting obligations vary by jurisdiction. Examination items test the recognition of reportable diseases and the appropriate response, not the specific regulatory details of any single country.

Hematologic and Immunologic Principles

Anemia classification by regenerative status and red blood cell morphology forms a core examination concept. The reticulocyte response distinguishes regenerative from nonregenerative anemia, and the morphology of the regenerative response, such as spherocytes in immune-mediated hemolytic anemia or acanthocytes in microangiopathic disease, directs further testing. The direct agglutination test and flow cytometry for cell-bound antibodies confirm immune-mediated disease.

Thrombocytopenia and coagulopathy items test the distinction between primary hemostatic disorders, such as thrombocytopenia and von Willebrand disease, and secondary hemostatic disorders, such as vitamin K antagonist toxicity and disseminated intravascular coagulation. The buccal mucosal bleeding time, platelet count, and coagulation panel provide the diagnostic framework. Examination items frequently test the expected laboratory findings for each disorder instead of the treatment protocols.

Endocrine Emergencies: Recognition and Stabilization

Diabetic ketoacidosis (DKA), hypoadrenocorticism, and thyrotoxic crisis represent the endocrine emergencies most likely to appear in NAVLE scenarios. Each follows a recognizable pattern of presentation, and the examination rewards a structured approach to diagnosis and initial therapy.

Diabetic Ketoacidosis

The classic DKA patient is a middle-aged dog or cat with polyuria, polydipsia, anorexia, vomiting, and dehydration. Cats may present with a plantigrade stance or unkempt haircoat. The diagnosis rests on the triad of hyperglycemia, ketonemia or ketonuria, and metabolic acidosis. Serum ketone measurement using beta-hydroxybutyrate meters is more specific than urine dipstick testing, which detects acetoacetate and may underestimate ketosis.

Initial assessment must include hydration status, perfusion parameters, electrolyte concentrations, and acid-base status. Potassium is the electrolyte most likely to complicate therapy. Total body potassium depletion is typical even when the initial measured value is normal or high, because acidosis shifts potassium extracellularly. Insulin therapy and correction of acidosis drive potassium back into cells, and hypokalemia can develop rapidly.

Fluid therapy begins with isotonic crystalloids to restore perfusion. The choice of fluid depends on the measured sodium concentration. Patients with marked hypernatremia may benefit from 0.45% sodium chloride once perfusion is restored, while those with normal or low sodium receive 0.9% sodium chloride. Regular insulin is administered by continuous rate infusion or intermittent intramuscular injection. Blood glucose should be monitored every one to two hours initially, and dextrose is added to the fluids when glucose falls below approximately 250 mg/dL. The goal is gradual glucose reduction, not rapid normalization.

Potassium supplementation should begin once the patient is producing urine and the measured potassium is below the reference range or trending downward. Current formulary references must be consulted for specific supplementation rates, as protocols vary by species and hospital setting. Phosphorus monitoring is warranted in cats and in any patient with hemolysis or weakness, though routine supplementation is no longer recommended unless the patient is symptomatic.

Hypoadrenocorticism

The classic Addisonian patient presents with lethargy, weakness, vomiting, diarrhea, and collapse. Bradycardia with a weak pulse, instead of tachycardia, is a distinguishing feature. Hyperkalemia with hyponatremia and a sodium-to-potassium ratio below 27:1 supports the diagnosis, but the ratio is not pathognomonic. The definitive diagnosis requires an ACTH stimulation test, which should be performed before or immediately after initial stabilization, because exogenous glucocorticoid administration can confound the results.

Stabilization begins with intravenous fluid therapy using 0.9% sodium chloride to correct hypovolemia and hyperkalemia. The electrocardiogram may show bradycardia, peaked T waves, or absent P waves in severe hyperkalemia. Calcium gluconate is indicated for cardiotoxic changes, while insulin and dextrose or beta-agonists are reserved for refractory cases. Glucocorticoid replacement should not be delayed for the ACTH test if the patient is unstable, but the test should be performed before glucocorticoid administration whenever possible. Mineralocorticoid replacement with desoxycorticosterone pivalate or fludrocortisone is initiated once the patient is stable and the diagnosis is confirmed.

The atypical Addisonian patient, lacking hyperkalemia, is a recognized diagnostic trap. Any dog with waxing and waning gastrointestinal signs, a stress leukogram that fails to develop, or a poor response to standard symptomatic therapy warrants an ACTH stimulation test.

Urinary Tract Disease: Localization and Management

The urinary system generates questions that test localization of disease, interpretation of urinalysis, and staging of chronic kidney disease. The International Renal Interest Society (IRIS) staging system for chronic kidney disease is the framework most commonly referenced in NAVLE preparation materials. Staging is based on fasting creatinine concentration measured on two occasions in a stable patient, with substaging based on proteinuria and blood pressure.

Acute Kidney Injury versus Chronic Kidney Disease

Differentiating acute kidney injury (AKI) from chronic kidney disease (CKD) changes the diagnostic plan and prognosis. Historical features favoring CKD include long-standing polyuria and polydipsia, poor body condition, nonregenerative anemia, and small or irregular kidneys on palpation or imaging. Acute kidney injury is suggested by a recent inciting event such as toxin exposure, hypotension, or drug administration, and by normal or enlarged kidneys. The distinction is not always clear, and patients with chronic disease can experience acute decompensation.

Urinalysis is the single most informative test. Isosthenuria in a dehydrated patient confirms the kidneys cannot concentrate urine. Active sediment with casts, particularly granular or cellular casts, supports tubulointerstitial injury. Glucosuria with normal blood glucose indicates proximal tubular dysfunction. Urine culture is indicated in any patient with suspected pyelonephritis, which is suggested by fever, leukocytosis, and bacteriuria with an inflammatory sediment.

Proteinuria and Hypertension

Proteinuria is both a marker of disease progression and a therapeutic target. The urine protein-to-creatinine ratio (UPC) quantifies protein loss, and a ratio above 0.5 in dogs or 0.4 in cats with CKD is associated with worse outcomes. Angiotensin-converting enzyme inhibitors are the first-line therapy for proteinuric CKD, with the goal of reducing the UPC below the threshold. Blood pressure measurement is essential, as systemic hypertension is both a cause and a consequence of renal disease. Systolic pressure above 160 mmHg with evidence of target organ damage, or above 180 mmHg without, warrants antihypertensive therapy. Amlodipine is the preferred agent in cats, while dogs may require combination therapy.

Hepatic Disease: Diagnostic Approach and Management

Hepatic disease spans congenital portosystemic shunts, chronic hepatitis, cholangitis, and hepatic lipidosis. The diagnostic approach prioritizes distinguishing primary hepatic disease from secondary involvement, and differentiating medical from surgical disease.

Portosystemic Shunts

A young dog or cat with neurologic signs after eating, ptyalism, stunted growth, and ammonium biurate crystalluria is the classic presentation for a congenital portosystemic shunt. Baseline laboratory findings include low blood urea nitrogen, low albumin, low cholesterol, and elevated fasting bile acids. The diagnosis is confirmed by imaging, with abdominal ultrasound being the most accessible modality, though computed tomography angiography is more sensitive and provides surgical planning information. Medical management with a restricted protein diet, lactulose, and antibiotics is appropriate for stabilization and for patients that are not surgical candidates, but surgical attenuation offers the best long-term outcome for suitable patients.

Hepatic Lipidosis in Cats

Hepatic lipidosis is the most common hepatobiliary disease in cats and is typically triggered by a period of anorexia. The diagnosis is supported by icterus, elevated liver enzymes, and ultrasonographic findings of a hyperechoic liver, with histopathology confirming the diagnosis. The central element of therapy is nutritional support, which requires placement of an esophagostomy or gastrostomy tube in most patients. The prognosis is good if nutritional support is established early and the underlying trigger is identified. The MSD Veterinary Manual provides detailed guidance on the diagnostic and therapeutic approach to feline hepatic lipidosis.

Pancreatic Disease

Pancreatitis is a common NAVLE topic because it crosses species and presents with variable clinical signs. In dogs, the classic presentation is vomiting, cranial abdominal pain, and anorexia. Cats are more challenging, presenting with lethargy, anorexia, and weight loss, often without vomiting or abdominal pain. Feline pancreatic lipase immunoreactivity (fPLI) is the most sensitive serum test in cats, while the canine pancreatic lipase immunoreactivity (cPLI) test has good sensitivity and specificity in dogs. Abdominal ultrasound supports the diagnosis by showing an enlarged, hypoechoic pancreas with surrounding hyperechoic mesentery.

Treatment is supportive and includes intravenous fluids, antiemetics, analgesia, and early enteral nutrition. The historical practice of withholding food is no longer supported. Patients with concurrent diabetes mellitus or inflammatory bowel disease require coordinated management, as the triad of pancreatitis, diabetes, and cholangitis is well recognized in cats.

Disease Summary Table

The ICVA NAVLE candidate information describes the examination structure and content domains that guide prioritization of these topics. The AVMA practice resources provide additional context on professional standards for managing chronic disease and communicating with clients about long-term therapy.

Recognized Complications and Early Detection

Endocrine and metabolic therapies carry predictable failure modes. In diabetic patients, the most consequential complication is hypoglycemia from insulin overdose, missed meals, or increased exercise. Early detection relies on owner-reported episodes of weakness, ataxia, or seizures, and on serial blood glucose curves performed in hospital. Somogyi phenomenon, rebound hyperglycemia after undetected hypoglycemia, is suspected when clinical signs of hypoglycemia alternate with persistent hyperglycemia. A glucose curve that shows values below the reference interval followed by rising glucose supports the diagnosis. MSD Veterinary Manual professional reference describes the interpretation of serial glucose measurements in monitoring insulin therapy.

Chronic kidney disease progression is monitored through serial creatinine, symmetric dimethylarginine, and urine protein-to-creatinine ratio. A sudden rise in creatinine out of proportion to the chronic trend should prompt investigation for dehydration, urinary obstruction, or pyelonephritis instead of automatic dose adjustment. Hypertension in renal patients can cause acute blindness from retinal detachment, detected on fundic examination before owners notice vision loss. AVMA practice resources provide guidance on routine monitoring protocols for chronic disease.

Hepatic lipidosis in cats is complicated by refeeding syndrome when aggressive enteral nutrition is introduced after prolonged anorexia. Hypophosphatemia, hypokalemia, and hemolytic anemia are the sentinel findings. Serial electrolyte measurement during the first week of feeding detects this before clinical deterioration.

Common Clinical Errors and Corrective Actions

Less experienced clinicians frequently misinterpret polyuria and polydipsia as diabetes mellitus without first measuring urine glucose. Diabetes insipidus, chronic kidney disease, hyperadrenocorticism, and pyometra all present with identical histories. The corrective action is to obtain a minimum database including biochemistry, urinalysis, and urine culture before initiating therapy.

Insulin dosing errors are common. Adjusting dose based on a single glucose reading instead of a curve, or increasing dose after one episode of hyperglycemia without considering stress hyperglycemia, leads to instability. The corrective action is to evaluate trends over 7 to 14 days and to use a consistent sampling protocol.

In hypoadrenocorticism, administering glucocorticoids before the ACTH stimulation test invalidates the diagnosis. The corrective action is to collect baseline cortisol, perform the stimulation test, and only then begin treatment. Mineralocorticoid replacement without glucocorticoid coverage in a stressed patient can precipitate a crisis.

Pancreatitis is overdiagnosed when lipase elevation is interpreted without clinical correlation. Canine pancreatic lipase immunoreactivity is sensitive but not specific, and renal disease reduces its clearance. The corrective action is to require compatible clinical signs and imaging findings before committing to the diagnosis.

Troubleshooting Table

Evidence Limitations and Expert Disagreement

The evidence base for several internal medicine interventions remains contested. The optimal target for blood pressure in proteinuric renal disease is debated, with some authorities recommending lower thresholds than others. The MSD Veterinary Manual professional reference presents ranges instead of fixed targets, reflecting this uncertainty.

Insulin therapy protocols for diabetic ketoacidosis vary between continuous rate infusion and intermittent intramuscular injection. Both are effective, but no large comparative trial establishes superiority. Expert opinion differs on whether routine use of phosphate supplementation is warranted or should be reserved for documented deficiency.

The role of dietary protein restriction in chronic kidney disease remains contentious. Some specialists advocate moderate restriction to reduce azotaemia, while others emphasize maintaining muscle mass and argue that protein restriction has limited survival benefit. Current guidance favours individualised nutrition based on disease stage and body condition.

Referral and Reporting Thresholds

Referral to an internal medicine specialist is warranted when a patient fails to stabilize despite appropriate therapy, when advanced imaging is required, or when a procedure such as dialysis, ureteral stenting, or endoscopic intervention is contemplated. Cases of suspected insulinoma, phaeochromocytoma, or atypical hypoadrenocorticism benefit from specialist evaluation before long-term therapy is committed.

Laboratory involvement is appropriate when point-of-care testing yields results inconsistent with clinical findings, when exotic or uncommon assays are needed, or when cytology or histopathology interpretation is required. A clinical pathologist can clarify artefactual results, such as hemolysis affecting potassium or lipaemia affecting spectrophotometric assays.

Regulatory reporting obligations vary by jurisdiction and production system. Suspected foreign animal diseases, including foot-and-mouth disease and African swine fever, must be reported to the relevant animal health authority. The WOAH terrestrial animal health standards define notifiable diseases and surveillance expectations for member countries. ICVA NAVLE candidate information confirms that knowledge of reportable disease recognition is expected of entry-level practitioners. Clinicians should know the reporting pathway in their region before an index case presents.

Frequently Asked Questions

How Do I Prioritize Diagnostic Testing When the Owner Has a Limited Budget?

Start with the minimum data base: complete blood count, serum biochemistry panel, urinalysis, and a baseline blood pressure measurement. These tests localize most disease processes and guide whether further testing is justified. If the owner cannot afford the full panel, prioritize the biochemistry profile and urinalysis for suspected metabolic or renal disease, or the complete blood count for suspected inflammatory or neoplastic conditions. Imaging can be staged, beginning with survey radiographs before advanced imaging. Explain that each test narrows the differential list and prevents spending on treatments aimed at the wrong disease. Document the owner's financial constraints and the diagnostic plan agreed upon in the medical record.

What Do I Do When Advanced Imaging Is Unavailable for a Suspected Portosystemic Shunt?

Preprandial and postprandial serum bile acid measurements remain the most accessible screening test when advanced imaging is unavailable. A fasting bile acid concentration within the reference interval makes a congenital shunt unlikely, though false negatives occur. If bile acids are equivocal, consider a trial of medical management with a protein-restricted diet and lactulose while monitoring clinical signs. Ammonia tolerance testing carries higher risk and is rarely performed. When medical management fails or clinical signs progress, referral for computed tomographic angiography or nuclear scintigraphy is indicated, as these modalities confirm the diagnosis and define vascular anatomy before surgical correction. The MSD Veterinary Manual provides detailed guidance on interpreting bile acid results and medical stabilization protocols.

How Does the Diagnostic Approach to Proteinuria Differ Between Dogs and Cats?

In dogs, glomerular disease is the primary concern, so urine protein-to-creatinine ratio, blood pressure measurement, and assessment for infectious or inflammatory triggers take priority. In cats, proteinuria is more often secondary to chronic kidney disease or hyperthyroidism, and the magnitude of proteinuria is typically lower. A urine protein-to-creatinine ratio above 0.5 in dogs or above 0.4 in cats warrants investigation, but concurrent urine sediment examination is essential to exclude post-renal proteinuria from hemorrhage or inflammation. Antihypertensive therapy with amlodipine is first-line in cats, while dogs more often require angiotensin-converting enzyme inhibitors. Recheck the ratio and blood pressure two to four weeks after initiating therapy.

What Record-Keeping Elements Are Critical for Managing a Chronic Endocrine Case?

Document the initial diagnostic criteria, including baseline hormone concentrations, imaging findings, and any dynamic test results. Record the starting drug dose, the brand and formulation dispensed, and the planned recheck interval. At each recheck, note body weight, clinical sign scores, blood pressure, and relevant laboratory values, then state the dose adjustment made and the rationale. For diabetic patients, log insulin type, syringe size, administration technique, and any episodes of hypoglycemia. For hypoadrenocorticoid patients, record mineralocorticoid and glucocorticoid doses separately and note stress-dose instructions provided to the owner. This documentation supports continuity across clinicians and defensible medical decisions. The AVMA practice resources offer guidance on medical record standards.

How Should I Explain a Poor Prognosis to a Client Without Discouraging Further Treatment?

Frame the conversation around goals of care instead of a single prognosis. State what the diagnosis means for the pet's expected quality of life, which clinical signs are likely to appear first, and which interventions offer meaningful benefit. Distinguish between treatments that slow disease progression and those that only palliate signs. Offer a concrete monitoring plan with defined triggers for re-evaluation or a shift to comfort-focused care. Acknowledge uncertainty honestly, and invite the client to share their priorities and constraints. This approach preserves the client's role in decision-making while ensuring they understand the clinical reality.

When Should I Report a Disease to Regulatory Authorities, and How Does This Differ Across Species?

Reportable diseases vary by jurisdiction and species, so veterinarians must know the list for their region. In production animals, diseases such as foot-and-mouth disease, highly pathogenic avian influenza, and bovine spongiform encephalopathy require immediate notification to the relevant animal health authority. In companion animals, rabies is the most common reportable disease, and suspected cases require prompt local health department contact. The World Organization for Animal Health terrestrial code defines international notification obligations, while national and state agencies maintain their own lists. When uncertain, contact the state or provincial veterinarian before acting. Document the report, the agency contacted, and the advice received in the medical record.

Related Clinical & Scientific Guides

• Developing a Study Schedule for NAVLE Diagnostic Reasoning
• Veterinary Physiology Concepts Frequently Tested on the NAVLE
• NAVLE Clinical Rotation Preparation: What to Review Before Each Service

References and Further Reading

• ICVA NAVLE Candidate Information. ICVA.
• AAVMC Veterinary Education Resources. AAVMC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Veterinary Anatomy High-Yield Topics for the NAVLE
• Veterinary Microbiology High-Yield Topics for the NAVLE
• Veterinary Pharmacology and Toxicology: High-Yield Topics for NAVLE
• Veterinary Parasitology for the NAVLE: High-Yield Parasites
• High-Yield Pharmacology Drug Interactions for the NAVLE

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.